Citation 67198

GUSTAFSON,KR: MUNRO,MHG: BLUNT,JW: CARDELLINA II,JH: MC MAHON,JB: GULAKOWSKI,RJ: CRAGG,GM: COX,PA: BRINEN,LS: CLARDY,J: BOYD,MR:. (1991). HIV INHIBITORY NATURAL PRODUCTS. 3. DITERPENES FROM HOMALANTHUS ACUMINATUS AND CHRYSOBALANUS ICACO.. 47(26)

Citation Details

Title	HIV INHIBITORY NATURAL PRODUCTS. 3. DITERPENES FROM HOMALANTHUS ACUMINATUS AND CHRYSOBALANUS ICACO.
Authors	GUSTAFSON,KR: MUNRO,MHG: BLUNT,JW: CARDELLINA II,JH: MC MAHON,JB: GULAKOWSKI,RJ: CRAGG,GM: COX,PA: BRINEN,LS: CLARDY,J: BOYD,MR:
Year	1991
Volume	47
Issue	26

Summary

Year: 1991

Journal: Unknown

Organisms and Their Experiments (2)

Homalanthus acuminatus (EUPHORBIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ATIS-16(17)-ENE-1-14-DIONE,3(S)-HYDROXY: ENT:	None
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ATIS-16(17)-ENE-1-14-DIONE,3(S)-HYDROXY: ENT:	ACTIVE
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ATIS-16(17)-ENE-1-14-DIONE,3(S)-HYDROXY: ENT:	ACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ATIS-16(17)-ENE-1-14-DIONE,3(S)-HYDROXY: ENT:	ACTIVE
5	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	ATISAN-3-ONE,16(S)-17-DIHYDROXY: ENT:	None
6	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ATISAN-3-ONE,16(S)-17-DIHYDROXY: ENT:	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ATISAN-3-ONE,16(S)-17-DIHYDROXY: ENT:	ACTIVE
8	Not specified	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	KAURAN-2-ONE,3(S)-16(S)-17-TRIHYDROXY: ENT:	None
9	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAURAN-2-ONE,3(S)-16(S)-17-TRIHYDROXY: ENT:	ACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	KAURAN-2-ONE,3(S)-16(S)-17-TRIHYDROXY: ENT:	ACTIVE
11	Not specified	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	KAURAN-3-ONE,16(S)-17-DIHYDROXY: ENT:	None
12	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAURAN-3-ONE,16(S)-17-DIHYDROXY: ENT:	ACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	KAURAN-3-ONE,16(S)-17-DIHYDROXY: ENT:	ACTIVE

Chrysobalanus icaco (CHRYSOBALANACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	KAUR-16-EN-19-OIC ACID,15-OXO: ENT:	None
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAUR-16-EN-19-OIC ACID,15-OXO: ENT:	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	KAUR-16-EN-19-OIC ACID,15-OXO: ENT:	ACTIVE
4	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	KAUR-16-EN-19-OIC ACID,11(S)-HYDROXY-15-OXO: ENT: METHYL ESTER	None
5	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	KAUR-16-EN-19-OIC ACID,11(S)-HYDROXY-15-OXO: ENT: METHYL ESTER	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	KAUR-16-EN-19-OIC ACID,11(S)-HYDROXY-15-OXO: ENT: METHYL ESTER	ACTIVE